Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Capital Leases: 2017-2024

Historic Capital Leases for Organogenesis Holdings (ORGO) over the last 6 years, with Dec 2024 value amounting to $718,000.

  • Organogenesis Holdings' Capital Leases rose 105.50% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 105.50%. This contributed to the annual value of $718,000 for FY2024, which is 61.97% down from last year.
  • Organogenesis Holdings' Capital Leases amounted to $718,000 in FY2024, which was down 61.97% from $1.9 million recorded in FY2023.
  • Organogenesis Holdings' 5-year Capital Leases high stood at $11.4 million for FY2020, and its period low was $718,000 during FY2024.
  • Its 2-year average for Capital Leases is $1.3 million, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, Organogenesis Holdings' Capital Leases increased by 20.71% in 2020 and then tumbled by 61.97% in 2024.
  • MRY analysis of 3 years shows Organogenesis Holdings' Capital Leases stood at $11.4 million in 2020, then plummeted by 83.50% to $1.9 million in 2023, then tumbled by 61.97% to $718,000 in 2024.
  • Its Capital Leases stands at $718,000 for FY2024, versus $1.9 million for FY2023 and $11.4 million for FY2020.